Business Combinations - Schedule of Pro Forma Results Effects of ICU Eyewear Acquisition (Details) - USD ($) |
12 Months Ended | |
|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
|
| Schedule of Pro Forma Results Effects of ICU Eyewear Acquisition [Abstract] | ||
| Revenues | $ 48,272,312 | $ 45,563,551 |
| Net income (loss) | 65,559,185 | (93,111,448) |
| Net income (loss) attributable to common shareholders | $ 65,795,303 | $ (92,844,801) |
| Basic earnings (loss) per share attributable to common shareholders (in Dollars per share) | $ 1.78 | $ (34.9) |
| Diluted loss per share attributable to common shareholders (in Dollars per share) | $ (0.01) | $ (34.9) |
| X | ||||||||||
- Definition Pro forma basic earnings per share or earnings per unit, which is commonly presented in initial public offerings based on the terms of the offering. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount, after tax, of pro forma income (loss) of combined entity as if acquisition date of business combination occurred as of beginning of period. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of pro forma revenue of combined entity as if acquisition date of business combination occurred as of beginning of period. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Pro forma diluted earnings per share, which is commonly presented in initial public offerings. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|